Fresenius Medical Care Affirms FY2026 Sales Guidance of $23.764B vs $22.940B Est

Benzinga Newsdesk www.benzinga.com Positive 61.4%

Neg 0% Neu 0% Pos 61.4%

Fresenius Medical Care (NYSE:FMS) affirms FY2026 sales outlook from $23.764 billion to $23.764 billion vs $22.940 billion estimate.